Clinical Trial Update: Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer [Phase 1, Phase 2]

View source ↗

Summary

An early-phase trial investigating a survivin peptide vaccine in patients with advanced melanoma, pancreatic cancer, colon cancer, and cervical cancer (Phase 1/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Colon Cancer
• Malignant Melanoma
• Pancreatic Cancer

Drugs mentioned

• Survivin peptide vaccine (Survivin peptide vaccine)

Snippet

Sponsor: Julius-Maximilians University | Conditions: Malignant Melanoma, Pancreatic Cancer | Phase 1, Phase 2 | Status: UNKNOWN